Factors Associated With Recurrence After Adjuvant Gemcitabine and Nab-Paclitaxel in Patients With Resected Pancreatic Ductal Adenocarcinoma.

Journal: Cancer medicine •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Xia T, Cheng C, Meng Y, et al. (2026). "Factors Associated With Recurrence After Adjuvant Gemcitabine and Nab-Paclitaxel in Patients With Resected Pancreatic Ductal Adenocarcinoma.". Cancer medicine. https://doi.org/10.1002/cam4.72491